RHESUS HAEMOLYTIC DISEASE OF NEWBORN

This adverse event was reported 13 times

These drugs are most commonly taken by patients reporting RHESUS HAEMOLYTIC DISEASE OF NEWBORN:

# Drug Count
0 AMPICILLIN 1
1 AMPICILLIN INJECTION 1
2 AMPICILLIN SODIUM 1
3 ECULIZUMAB 1
4 HUMAN IMMUNOGLOBULIN G 1
5 HUMAN RHO(D) IMMUNE GLOBULIN 1
6 INSULIN 1
7 INSULIN GLARGINE 1
8 METFORMIN HYDROCHLORIDE 1
9 NIFEDIPINE 1
See all common drugs associated with RHESUS HAEMOLYTIC DISEASE OF NEWBORN

RHESUS HAEMOLYTIC DISEASE OF NEWBORN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN RHO(D) IMMUNE GLOBULIN 1 0.0010
1 AMPICILLIN INJECTION 1 0.0001
2 AMPICILLIN 1 0.0001
3 HUMAN IMMUNOGLOBULIN G 1 0.0000
4 NIFEDIPINE 1 0.0000
5 ECULIZUMAB 1 0.0000
6 METFORMIN HYDROCHLORIDE 1 0.0000
7 INSULIN GLARGINE 1 0.0000
See all drugs enriched for association with RHESUS HAEMOLYTIC DISEASE OF NEWBORN

These drug classes are most commonly taken by patients reporting RHESUS HAEMOLYTIC DISEASE OF NEWBORN:

# Drug class Count
0 Human Immunoglobulin G [EPC] 2
1 Insulin Analog [EPC] 2
2 Complement Inhibitor [EPC] 1
3 Dihydropyridine Calcium Channel Blocker [EPC] 1
See all common drug classes associated with RHESUS HAEMOLYTIC DISEASE OF NEWBORN

RHESUS HAEMOLYTIC DISEASE OF NEWBORN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 2 0.0001
1 Complement Inhibitor [EPC] 1 0.0000
2 Insulin Analog [EPC] 2 0.0000
3 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
See all drug classes enriched for association with RHESUS HAEMOLYTIC DISEASE OF NEWBORN